Unveiling the intracellular dynamics of α4β2 nAChR-mediated ERK activation through the interplay of arrestin, Gβγ, and PKCβIILIFE SCIENCESIF5.12024-10-010PRE
From modulation of cellular plasticity to potentiation of therapeutic resistance: new and emerging roles of MYB transcription factors in human malignanciesCANCER AND METASTASIS REVIEWSIF8.72023-11-104OA
Comparative study of the molecular mechanisms underlying the G protein and β-arrestin-dependent pathways that lead to ERKs activation upon stimulation by dopamine D2 receptorFEBS JOURNALIF4.22023-08-113PRE
Frequent loss of CACNA1C, a calcium voltage-gated channel subunit is associated with lung adenocarcinoma progression and poor prognosisCANCER RESEARCHIF16.62023-04-040PRE
Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancerJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92023-01-015OAAI
Clinicopathologic significance and race-specific prognostic association of MYB overexpression in ovarian cancerSCIENTIFIC REPORTSIF3.92021-06-189OAAI
Structural Requirements for Modulating 4-Benzylpiperidine Carboxamides from Serotonin/Norepinephrine Reuptake Inhibitors to Triple Reuptake InhibitorsBIOMOLECULES & THERAPEUTICSIF3.22021-05-314OAAI
β-Arrestin1 and GPCR kinase2 play permissive roles in Src-mediated endocytosis of α4β2 nicotinic ACh receptorsBRITISH JOURNAL OF PHARMACOLOGYIF7.72021-05-206OAAI
Mdm2-mediated ubiquitination of PKCβII in the nucleus mediates clathrin-mediated endocytic activityBIOCHEMICAL PHARMACOLOGYIF5.62019-12-0117PREAI
Catalpol and Mannitol, Two Components of Rehmannia glutinosa, Exhibit Anticonvulsant Effects Probably via GABAA Receptor RegulationBIOMOLECULES & THERAPEUTICSIF3.22019-11-188OAAI
The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT2 receptorsPSYCHOPHARMACOLOGYIF3.32019-03-1918PREAI
Design, synthesis, and systematic evaluation of 4-arylpiperazine- and 4-benzylpiperidine napthyl ethers as inhibitors of monoamine neurotransmitters reuptakeBIOORGANIC & MEDICINAL CHEMISTRYIF32018-11-013PREAI
Triple reuptake inhibitors: Design, synthesis and structure-activity relationship of benzylpiperidine-tetrazolesBIOORGANIC & MEDICINAL CHEMISTRYIF32017-10-0116PREAI
Molecular Signature That Determines the Acute Tolerance of G Protein-Coupled ReceptorsBIOMOLECULES & THERAPEUTICSIF3.22017-05-0112OAAI
Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitorsBIOORGANIC & MEDICINAL CHEMISTRYIF32017-04-0112PREAI
Exploration of substituted arylpiperazine-tetrazoles as promising dual norepinephrine and dopamine reuptake inhibitorsBIOORGANIC & MEDICINAL CHEMISTRYIF32016-11-0110PREAI
Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activitiesBIOORGANIC & MEDICINAL CHEMISTRYIF32016-05-0114PREAI
Design, synthesis and evaluation of bitopic arylpiperazinephenyl-1,2,4-oxadiazoles as preferential dopamine D3 receptor ligandsBIOORGANIC & MEDICINAL CHEMISTRYIF32016-01-0117PREAI
Physicochemical characterization of a thermostable glycoprotein bioemulsifier from Solibacillus silvestris AM1PROCESS BIOCHEMISTRYIF42013-11-0143PREAI